Acurx Pharmaceuticals

/Acurx Pharmaceuticals

We are a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization (“WHO”), the U.S. Centers for Disease Control and Prevention (“CDC”), and the U.S. Food and Drug Administration (“FDA”).

Symbol

Price Range
$5.00 - $7.00

Final Shares
2,500,000

Anticipated Date
June 25, 2021

Underwriters

This offering is no longer available

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange